Is Globe Life (GL) Offering Value After Recent Share Price Strength?

• Investors may be wondering whether Globe Life at US$147.85 is offering value right now, or if the recent share price move means they are late to the story.
• The stock has returned 5.3% over the last 7 days, 4.1% over the past month and 6.8% year to date, with a 21.6% return over 1 year, 41.4% over 3 years and 51.6% over 5 years.
• Recent coverage of Globe Life has focused on its position in the US insurance sector, with attention on how investors are weighing the stock against broader industry peers. This context is helping shape views on risk, capital strength and growth options, which can all influence how the market prices the shares.
• Globe Life currently has a valuation score of 5 out of 6. The rest of this article will unpack what different valuation approaches suggest about that score and will point to a more complete way to think about value at the end.

Globe Life delivered 21.6% returns over the last year. See how this stacks up to the rest of the Insurance industry.

Approach 1: Globe Life Excess Returns Analysis

The Excess Returns model looks at how much profit a company is expected to generate above the return that equity investors typically require, then capitalizes those “extra” earnings into a per share value.

For Globe Life, the starting point is its book value of $75.54 per share and an average return on equity of 17.70%. Analysts expect stable earnings of $16.48 per share, based on weighted future Return on Equity estimates from 4 analysts. The model assumes a cost of equity of $6.50 per share, so the implied excess return is $9.98 per share, the amount above that required return.

The analysis also uses a stable book value estimate of $93.15 per share, sourced from weighted future Book Value estimates from 5 analysts. Combining these inputs, the Excess Returns model points to an intrinsic value of about $372.95 per share. Compared with the current share price of US$147.85, this suggests that Globe Life is 60.4% undervalued on this measure.

Result: UNDERVALUED

Our Excess Returns analysis suggests Globe Life is undervalued by 60.4%. Track this in your watchlist or portfolio, or discover 64 more high quality undervalued stocks.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Globe Life.

Approach 2: Globe Life Price vs Earnings

P/E is a common way to value profitable companies because it links what you pay per share to what the company currently earns per share. For you as an investor, it is a quick shorthand for how many dollars the market is paying for each dollar of earnings.

What counts as a “normal” or “fair” P/E usually reflects how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk often support a higher P/E, while weaker growth expectations or higher risk tend to align with a lower P/E.

Globe Life trades on a P/E of 9.99x. That is below the Insurance industry average of about 11.47x and also below the peer group average of 12.93x. Simply Wall St’s Fair Ratio for Globe Life is 11.81x. This Fair Ratio is a proprietary estimate of what the P/E might be given the company’s earnings profile, industry, profit margins, market cap and risk factors. It can be more informative than a simple comparison with peers or the broad industry because it adjusts for company specific characteristics rather than relying only on group averages.

Comparing Globe Life’s actual P/E of 9.99x with the Fair Ratio of 11.81x indicates that the shares are trading below that Fair Ratio estimate.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Globe Life Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced here as a simple tool on Simply Wall St’s Community page that lets you connect your view of Globe Life’s story to a concrete forecast for revenue, earnings, margins and fair value. You can then compare that fair value with the current share price to guide your own buy or sell timing. Each Narrative updates automatically as new earnings or news arrive and can reflect very different perspectives. For example, there is a more pessimistic view that assumes a fair value of US$150 per share and a P/E of 9.6x in 2029, versus a more optimistic view that assumes a fair value of US$199 per share and a P/E of 11.5x in 2028.

Do you think there's more to the story for Globe Life? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com